Immediate Impact

46 standout
Sub-graph 1 of 19

Citing Papers

European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Update
2024 Standout
Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2024 Standout
3 intermediate papers

Works of Dennis Robins being referenced

Collecting duct carcinoma of the kidney: Disease characteristics and treatment outcomes from the National Cancer Database
2017
Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non–muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy
2017

Author Peers

Author Last Decade Papers Cites
Dennis Robins 169 83 95 17 299
Giovanni Motterle 105 27 111 25 305
Marcelo Langer Wroclawski 76 57 126 13 306
Lucas Wiegand 182 144 60 35 335
Jan‐Niclas Mumm 48 53 39 24 282
Ifeanyi Onyeji 213 76 69 20 308
Robert Dotzauer 89 31 100 29 314
Katy Wang 125 52 42 20 319
Antônio José Gonçalves 88 37 79 28 303
Brian V. Le 90 41 120 14 327
Anita Thomas 171 51 35 12 324

All Works

Loading papers...

Rankless by CCL
2026